Literature DB >> 2174808

Human pancreatic islet cell specific 38 kilodalton autoantigen identified by cytomegalovirus-induced monoclonal islet cell autoantibody.

C Y Pak1, C Y Cha, R V Rajotte, R G McArthur, J W Yoon.   

Abstract

Our previous finding that about 15% of newly diagnosed patients with Type 1 (insulin-dependent) diabetes mellitus had human cytomegalovirus genome in their lymphocytes and islet cell autoantibodies in their sera, suggests that autoimmune Type 1 diabetes is associated with persistent cytomegalovirus infection under certain circumstances. This investigation was initiated to see if cytomegalovirus can induce islet cell autoantibodies and if the autoantibodies react with any specific islet protein(s). Monoclonal antibodies were generated after immunizing Balb/c mice with human cytomegalovirus. When these monoclonal antibodies were tested for the presence of islet cell antibodies were tested for the presence of islet cell antibodies, one (MCMVA-51) of 13 monoclonal antibodies reacted strongly with the islets. The titer of islet cell antibodies was 1:2000. When this monoclonal antibody was reacted with the proteins from the solubilized fraction of human pancreatic islets using the western immunoblotting technique, a band with a molecular weight of 38 kilodalton was detected. The 38 kilodalton band was not observed when the monoclonal antibody was reacted with the proteins prepared from pancreatic islet tissues of rats and mice or from other human organs including stomach, liver, spleen and brain, indicating that the 38 kilodalton protein is human islet cell-specific. It is concluded that human cytomegalovirus can induce islet cell antibodies that react with a 38 kilodalton human islet cell protein and that this protein component may represent islet cell-specific target antigens associated with persistent cytomegalovirus infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174808     DOI: 10.1007/BF00404146

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

Review 1.  Pathogenic mechanisms of virus-induced type 1 diabetes.

Authors:  J W Yoon
Journal:  Microb Pathog       Date:  1988-08       Impact factor: 3.738

2.  Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues.

Authors:  J Srinivasappa; J Saegusa; B S Prabhakar; M K Gentry; M J Buchmeier; T J Wiktor; H Koprowski; M B Oldstone; A L Notkins
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

3.  Molecular mimicry and autoimmune disease.

Authors:  M B Oldstone
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

4.  Congenital cytomegalovirus infection and diabetes.

Authors:  K P Ward; W H Galloway; I A Auchterlonie
Journal:  Lancet       Date:  1979-03-03       Impact factor: 79.321

5.  Association of beta-cell-specific expression of endogenous retrovirus with development of insulitis and diabetes in NOD mouse.

Authors:  K Suenaga; J W Yoon
Journal:  Diabetes       Date:  1988-12       Impact factor: 9.461

6.  Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins.

Authors:  S Baekkeskov; J H Nielsen; B Marner; T Bilde; J Ludvigsson; A Lernmark
Journal:  Nature       Date:  1982-07-08       Impact factor: 49.962

7.  Congenital rubella syndrome as a model for type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies.

Authors:  F Ginsberg-Fellner; M E Witt; S Yagihashi; M J Dobersen; F Taub; B Fedun; R C McEvoy; S H Roman; R G Davies; L Z Cooper
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

8.  Identification of antigenic differences between the diabetogenic and non-diabetogenic variants of encephalomyocarditis virus using monoclonal antibodies.

Authors:  J W Yoon; W Ko; Y S Bae; C Y Pak; K Amano; H M Eun; M K Kim
Journal:  J Gen Virol       Date:  1988-05       Impact factor: 3.891

9.  Association of cytomegalovirus infection with autoimmune type 1 diabetes.

Authors:  C Y Pak; H M Eun; R G McArthur; J W Yoon
Journal:  Lancet       Date:  1988-07-02       Impact factor: 79.321

10.  Pancreatic islet-cell damage in children with fatal viral infections.

Authors:  A B Jenson; H S Rosenberg; A L Notkins
Journal:  Lancet       Date:  1980-08-16       Impact factor: 79.321

  10 in total
  15 in total

1.  Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase.

Authors:  H S Hiemstra; N C Schloot; P A van Veelen; S J Willemen; K L Franken; J J van Rood; R R de Vries; A Chaudhuri; P O Behan; J W Drijfhout; B O Roep
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

Review 2.  Immune cell crosstalk in type 1 diabetes.

Authors:  Agnès Lehuen; Julien Diana; Paola Zaccone; Anne Cooke
Journal:  Nat Rev Immunol       Date:  2010-07       Impact factor: 53.106

Review 3.  Novel biomarkers in type 1 diabetes.

Authors:  Yulan Jin; Jin-Xiong She
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 4.  The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure.

Authors:  Bart O Roep
Journal:  Diabetologia       Date:  2003-03-22       Impact factor: 10.122

Review 5.  Pharmacological approaches to the prevention of autoimmune diabetes.

Authors:  W E Winter; D V House; D Schatz
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

6.  T-cell reactivity to 38 kD insulin-secretory granule protein in patients with recent onset type 1 diabetes.

Authors:  E Bonifacio; C Boitard
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

Review 7.  The role of infections in autoimmune disease.

Authors:  A M Ercolini; S D Miller
Journal:  Clin Exp Immunol       Date:  2009-01       Impact factor: 4.330

Review 8.  Diabetes mellitus due to viruses--some recent developments.

Authors:  T M Szopa; P A Titchener; N D Portwood; K W Taylor
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

9.  Induction of an organ-specific autoimmune disease, lymphocytic hypophysitis, in hamsters by recombinant rubella virus glycoprotein and prevention of disease by neonatal thymectomy.

Authors:  J W Yoon; D S Choi; H C Liang; H S Baek; I Y Ko; H S Jun; S Gillam
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

10.  No detectable cytomegalovirus and Epstein-Barr virus genomes in the pancreas of recent-onset IDDM patients.

Authors:  N Itoh; T Hanafusa; K Yamagata; H Nakajima; K Tomita; S Tamura; M Inada; S Kawata; N Kono; M Kuwajima
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.